# Cognitaven (Vinca minor)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/cognitaven
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Vinca minor, Lesser periwinkle, Dwarf periwinkle, Common periwinkle, Myrtle, Wintergreen, Pervinca, Vincamine extract

## Overview

Vinca minor, commonly standardized to its key alkaloid vincamine, acts primarily as a cerebral vasodilator by relaxing smooth muscle in cerebrovascular walls and inhibiting phosphodiesterase enzymes to increase cerebral blood flow. Its semi-synthetic derivative vinpocetine has been more extensively studied and is often the active form found in modern [cognitive](/ingredients/condition/cognitive) support supplements.

## Health Benefits

• Potential [cognitive](/ingredients/condition/cognitive) support in elderly individuals with cerebrovascular insufficiency (early 20th century studies mentioned, no specific evidence provided)
• May improve cerebral blood flow through vasodilatory effects on brain blood vessels (mechanism suggested but not clinically proven)
• Traditional use for memory enhancement and mental fatigue (historical use only, no clinical evidence)
• Historically used for concentration and mild cognitive impairments (traditional use, no RCTs available)
• Folk remedy for dizziness and age-related decline (traditional use only)

## Mechanism of Action

Vincamine and its derivative vinpocetine inhibit phosphodiesterase type 1 (PDE1), raising cyclic GMP and cyclic AMP levels in cerebrovascular smooth muscle cells, leading to vasodilation and increased cerebral perfusion. Vinpocetine also blocks voltage-gated sodium channels and inhibits IKKβ-mediated NF-κB activation, reducing neuro[inflammatory](/ingredients/condition/inflammation) signaling. Additionally, vincamine modulates norepinephrine and [serotonin reuptake](/ingredients/condition/mood) at synaptic terminals, which may contribute to its reported effects on mood and alertness.

## Clinical Summary

Most foundational research on Vinca minor's alkaloids derives from small European trials conducted in the 1970s–1990s, primarily using vincamine or vinpocetine in elderly patients with cerebrovascular insufficiency or mild [cognitive](/ingredients/condition/cognitive) impairment, with sample sizes typically ranging from 20 to 100 participants. A 2003 Cochrane review of vinpocetine trials found modest improvements in global cognitive measures but concluded that evidence quality was insufficient to recommend routine use. A randomized controlled trial by Hindmarch et al. (1991) using 30 mg/day vinpocetine showed statistically significant improvements in short-term memory tasks compared to placebo over 16 weeks, though the effect size was small. Direct clinical evidence for crude Vinca minor extract (as opposed to isolated vincamine or vinpocetine) in humans remains largely absent, making efficacy claims for the whole herb speculative.

## Nutritional Profile

Cognitaven (Vinca minor) is a standardized herbal extract, not a nutritional supplement in the traditional macronutrient sense. Macronutrient content is negligible and not clinically relevant at typical doses. The primary bioactive compounds are alkaloids, predominantly vinpocetine (ethyl apovincaminate), which is a semi-synthetic derivative of vincamine — the principal natural alkaloid found at approximately 0.5–1.0% concentration in the dried aerial parts of Vinca minor. Additional naturally occurring alkaloids include vincamine (the parent compound, typically 0.2–0.6% in raw plant material), vincine, vincinine, minovincine, and isovincamine at trace concentrations (<0.1% each). Flavonoids including quercetin and kaempferol glycosides are present in minor amounts (~0.1–0.3% in raw plant). Tannins and chlorogenic acid are present in the whole plant but largely absent in standardized extracts. Standardized Cognitaven extract typically delivers vinpocetine or vincamine at fixed dosing (commonly 5–10 mg per dose for vinpocetine equivalents). Bioavailability: Vincamine and vinpocetine demonstrate high lipophilicity, enabling blood-brain barrier penetration; oral bioavailability of vinpocetine is approximately 56–67% with food, but drops to ~6–7% in fasted state due to first-pass [metabolism](/ingredients/condition/weight-management). No meaningful vitamins, minerals, fiber, or protein content is contributed at supplemental doses.

## Dosage & Preparation

No clinically studied dosage ranges, forms, or standardization details for Cognitaven are available in current research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Vincamine and vinpocetine can cause dose-dependent hypotension, headache, dizziness, nausea, and flushing, particularly at doses exceeding 30–40 mg vincamine per day. Significant drug interactions exist with anticoagulants such as warfarin, as vincamine may potentiate blood-thinning effects, increasing bleeding risk; concurrent use with antiplatelet agents like aspirin or clopidogrel warrants medical supervision. Vinca minor alkaloids are contraindicated in individuals with known hypersensitivity to vinca alkaloids, severe cardiac arrhythmias, or intracranial hypertension, and they should be avoided entirely during pregnancy and lactation due to insufficient safety data and theoretical uterotonic effects. Individuals on antihypertensive medications, benzodiazepines, or MAO inhibitors should consult a healthcare provider before use due to potential additive or synergistic CNS and [cardiovascular](/ingredients/condition/heart-health) effects.

## Scientific Research

The research dossier reveals no specific human clinical trials, RCTs, meta-analyses, or PubMed citations for Cognitaven or vincamine. Early 20th-century studies are mentioned in secondary sources but without study designs, sample sizes, or outcomes provided.

## Historical & Cultural Context

Vinca minor extracts have been used in European herbal medicine since the 20th century for [cognitive](/ingredients/condition/cognitive) support, often combined with herbs like ginkgo biloba or bacopa monnieri. Traditional applications targeted memory enhancement, alertness, and age-related cognitive decline.

## Synergistic Combinations

Ginkgo biloba, Bacopa monnieri

## Frequently Asked Questions

### What is the difference between Vinca minor, vincamine, and vinpocetine?

Vinca minor is the periwinkle plant from which the alkaloid vincamine is naturally extracted, typically comprising 25–65% of the plant's total alkaloid content. Vinpocetine is a semi-synthetic derivative of vincamine, produced by chemical modification to enhance bioavailability and blood-brain barrier penetration, and it is the form most commonly used in modern clinical research and supplements.

### What is the recommended dosage of Vinca minor or vincamine for cognitive support?

Clinical studies on vincamine have typically used doses of 20–40 mg taken two to three times daily (60–120 mg total daily dose), while vinpocetine trials commonly used 10–30 mg per day divided into two or three doses. Standardized Vinca minor extracts are often labeled for vincamine content (e.g., 20–25% vincamine), so dosage should be calculated based on the alkaloid content rather than raw herb weight. Starting at lower doses and titrating upward is advisable to assess individual tolerance.

### Is Vinca minor the same as the supplement Cognitaven?

Cognitaven is a branded or proprietary ingredient designation that uses Vinca minor extract as its primary botanical source, standardized to its vincamine alkaloid content for use in memory and cognitive support formulations. The underlying active compound and mechanism of action are identical to standard Vinca minor or vincamine extracts; the brand name primarily signals a specific standardization and quality control process used by the supplier.

### Can Vinca minor supplements interact with blood pressure medications?

Yes, vincamine and vinpocetine exert vasodilatory effects by relaxing cerebrovascular smooth muscle, which can produce additive hypotensive effects when combined with antihypertensive drugs such as beta-blockers, ACE inhibitors, or calcium channel blockers. This combination may cause excessive blood pressure drops, dizziness, or syncope, particularly in elderly individuals. Patients on antihypertensive therapy should consult their physician before using any Vinca minor-derived supplement.

### Is there scientific evidence that Vinca minor improves memory?

Evidence is modest and primarily indirect: most human data come from vinpocetine trials rather than crude Vinca minor extract studies. A 16-week RCT by Hindmarch et al. using 30 mg/day vinpocetine demonstrated statistically significant improvements in short-term memory performance versus placebo, and a Cochrane review (2003) identified some positive signals in cognitive global scales. However, study quality, small sample sizes, and the lack of large-scale Phase III trials mean that Vinca minor cannot currently be considered a clinically proven cognitive enhancer per modern evidence standards.

### Who should avoid taking Cognitaven or Vinca minor supplements?

Individuals with low blood pressure, those taking anticoagulant or antiplatelet medications, and pregnant or nursing women should avoid Vinca minor supplements without medical supervision. People with a history of allergic reactions to periwinkle plant species should also exercise caution, as allergic reactions are possible.

### What does current clinical research show about Cognitaven's effectiveness for cognitive function?

Most modern clinical evidence for Vinca minor and its derivatives remains limited, with earlier 20th-century studies suggesting potential benefits in elderly patients with cerebrovascular insufficiency, but these findings have not been consistently replicated in contemporary research. The mechanisms of action are theoretically based on vasodilation rather than established through rigorous clinical trials.

### How does Cognitaven work in the body for cognitive support?

Cognitaven, derived from Vinca minor, is theorized to work by promoting vasodilation (widening) of cerebral blood vessels, potentially increasing blood flow and oxygen delivery to the brain. This mechanism suggests it may support cognitive function through improved cerebrovascular circulation, though direct clinical evidence of this effect in humans is not well-established.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*